Yunching Chen
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 23
- Advanced biosensing and bioanalysis techniques 14
-
- Nanoplatforms for cancer theranostics 15
- Co-authors
- Leaf Huang (11 shared papers)Xiaodong Zhu (1 shared paper)Bin Liu (1 shared paper)Xiaoju Zhang (2 shared papers)Surendar Reddy Bathula (6 shared papers)Yun‐Chieh Sung (14 shared papers)Jinzi J. Wu (2 shared papers)Leaf Huang (3 shared papers)
- Journals
- ACS Applied Materials & Interfaces (5 papers)Journal of Controlled Release (5 papers)Hepatology (3 papers)Molecular Therapy (3 papers)Biomaterials (3 papers)
- Partner nations
- TaiwanUnited StatesUnited Kingdom
In The Last Decade
Yunching Chen
77 papers receiving 4.3k citations
Yunching Chen's Hit Papers
Peers
Comparison fields: 5 of 133
- Cancer Research 926
- Biomaterials 805
- Hepatology 388
- Immunology 808
- Molecular Biology 2.1k
Countries citing papers authored by Yunching Chen
This map shows the geographic impact of Yunching Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunching Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunching Chen more than expected).
Fields of papers citing papers by Yunching Chen
This network shows the impact of papers produced by Yunching Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunching Chen. The network helps show where Yunching Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Yunching Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | In vivo delivery of miRNAs for cancer therapy: Challenges and strategies Hit paper breakdown → | 2014 | 583 |
| 2 | 2010 | 440 | |
| 3 | CXCR4 inhibition in tumor microenvironment facilitates anti‐programmed death receptor‐1 immunotherapy in sorafenib‐treated hepatocellular carcinoma in mice Hit paper breakdown → | 2014 | 379 |
| 4 | 2020 | 221 | |
| 5 | 2010 | 188 | |
| 6 | 2013 | 177 | |
| 7 | 2010 | 158 | |
| 8 | 2015 | 122 | |
| 9 | 2015 | 110 | |
| 10 | 2020 | 107 | |
| 11 | 2015 | 101 | |
| 12 | 2010 | 100 | |
| 13 | 2015 | 88 | |
| 14 | 2017 | 87 | |
| 15 | 2011 | 86 | |
| 16 | 2009 | 84 | |
| 17 | 2016 | 77 | |
| 18 | 2021 | 68 | |
| 19 | 2015 | 68 | |
| 20 | 2020 | 65 |
About Yunching Chen
Yunching Chen is a scholar working on Molecular Biology, Biomedical Engineering, Immunology, Cancer Research and Oncology, having authored 85 papers that have together received 4.4k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (23 papers), Nanoplatforms for cancer theranostics (15 papers), Advanced biosensing and bioanalysis techniques (14 papers), Nanoparticle-Based Drug Delivery (8 papers), MicroRNA in disease regulation (8 papers), Immunotherapy and Immune Responses (7 papers), Liver physiology and pathology (6 papers) and Phagocytosis and Immune Regulation (6 papers). The work is most often cited by research in Cancer Research (926 citations), Biomaterials (805 citations), Hepatology (388 citations), Immunology (808 citations) and Molecular Biology (2.1k citations). Yunching Chen has collaborated with scholars based in Taiwan, United States and United Kingdom. Frequent co-authors include Leaf Huang, Xiaodong Zhu, Bin Liu, Xiaoju Zhang, Surendar Reddy Bathula, Yun‐Chieh Sung, Jinzi J. Wu, Leaf Huang, Jun Li and Yuhui Huang. Their work appears in journals such as ACS Applied Materials & Interfaces, Journal of Controlled Release, Hepatology, Molecular Therapy and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.